Atiprimod (azaspirane, SK&F106615)
Updated: Nov 14, 2009
| Brand Name: | Atiprimod |
| Generic Name: | azaspirane |
| Code Name: | SK&F106615 |
| Company: | Callisto Pharmaceuticals |
| FDA Clinical Phase: | 1/2 |
Description:
A substance being studied in the treatment of certain multiple myelomas and other advanced cancers. Atiprimod may block the growth of tumors and the growth of new blood vessels that tumors need to grow. Atiprimod is a type of signal transduction inhibitor.
Clinical Trials:
For a list of clinical trials studying Atiprimod for the treatment of multiple myeloma, see ClinicalTrials.gov.
Source: NCI Cancer Glossary, Atiprimod, http://www.cancer.gov/templates/db_alpha.aspx?searchTxt=Atiprimod (as of November 14, 2009)
Leave a comment